Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Debt to Assets Over Time
Trending lower, above historical average, strong compound growth.
Left:
||||
Debt-to-assets ratio
Latest
0.37
↑ 77% above average
Average (9y)
0.21
Historical baseline
Range
High:0.52
Low:0.00
CAGR
+25.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 0.37 | -29.2% |
| 2023 | 0.52 | +67.0% |
| 2022 | 0.31 | +69.4% |
| 2021 | 0.18 | -48.4% |
| 2020 | 0.35 | +43.9% |
| 2019 | 0.25 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.00 | -94.6% |
| 2016 | 0.04 | -9.8% |
| 2015 | 0.05 | - |